Information from Answers.com-
William J Hermann William J. Hermann, flying saucer contactee and channeler, emerged out of obscurity in 1978 after claiming to have had a series of commincations with captain kirk of the starship enterprise which was orbiting the planet ZorLovf. (star date: 2159)
Recent INDV News
- Indivior Announces Q1 2024 Financial Results • PR Newswire (US) • 04/25/2024 06:00:00 AM
- Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone • PR Newswire (US) • 03/11/2024 06:43:00 PM
- Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict Litigation • PR Newswire (US) • 02/29/2024 07:02:00 AM
- Indivior Announces Q4 / FY 2023 Financial Results • PR Newswire (US) • 02/22/2024 07:00:00 AM
- Indivior Announces Q3 2023 Financial Results • PR Newswire (US) • 11/09/2023 07:05:00 AM
- Indivior Announces Q3 2023 Financial Results • PR Newswire (US) • 11/09/2023 07:05:00 AM
- Indivior Enters an Exclusive Licensing Agreement with Alar Pharmaceuticals • PR Newswire (US) • 10/11/2023 08:20:00 PM
- Indivior Publishes Real World Data Showing SUBLOCADE® May Reduce Non-Fatal Overdoses Among Individuals with Opioid Use Disorder in Canada • PR Newswire (US) • 09/26/2023 06:30:00 PM
- Indivior Reaches Agreement with End Payor Class to Resolve Their Antitrust Multi-District Litigation Claims • PR Newswire (US) • 08/21/2023 06:02:00 AM
- Indivior Reaches Agreement with End Payor Class to Resolve Their Antitrust Multi-District Litigation Claims • PR Newswire (US) • 08/21/2023 06:02:00 AM
- Indivior Announces Q2/H1 2023 Financial Results • PR Newswire (US) • 07/27/2023 06:00:00 AM
- Indivior Announces Four Abstracts Accepted for Presentation at the 85th Annual Scientific Meeting of the College on Problems of Drug Dependence • PR Newswire (US) • 06/14/2023 05:53:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM